Dividendos de AnteoTech

Dividendo controles de criterios 0/6

AnteoTech no tiene historial de pago de dividendo.

Información clave

n/a

Rentabilidad por dividendo

n/a

Ratio de pago

Rentabilidad media de la industria	2.4%
Próxima fecha de pago de dividendos	n/a
Fecha ex dividendo	n/a
Dividendo por acción	n/a
Beneficios por acción	-AU$0.0048
Rentabilidad por dividendo prevista a 3 años	n/a

Últimas actualizaciones de dividendos

No hay actualizaciones

Recent updates

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: No hay datos suficientes para determinar si los dividendos por acción de ADO han sido estables en el pasado.

Dividendo creciente: Datos insuficientes para determinar si los pagos de dividendos de ADO han aumentado.

Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de AnteoTech vs. Mercado

¿Cómo se compara la rentabilidad por dividendo de ADO con la del mercado?
Segmento	Rentabilidad por dividendo
Empresa (ADO)	n/a
Suelo de mercado 25% (AU)	2.6%
Techo de mercado 25% (AU)	6.3%
Media de la industria (Chemicals)	2.4%
Previsión de analistas en 3 años (ADO)	n/a

Dividendo destacado: No es posible evaluar la rentabilidad por dividendo de ADO en comparación con el 25% inferior de los pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.

Alto dividendo: No es posible evaluar la rentabilidad por dividendo de ADO en comparación con el 25% de los principales pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.

Pago de beneficios a los accionistas

Cobertura de los beneficios: No hay datos suficientes para calcular el ratio de pago de ADO para determinar si sus pagos de dividendos están cubiertos por los beneficios.

Pago en efectivo a los accionistas

Cobertura de flujo de caja: No es posible calcular la sostenibilidad de los dividendos, ya que ADO no ha comunicado ningún pago.

Discover strong dividend paying companies

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Dividendos de AnteoTech

Dividendo controles de criterios 0/6

Información clave

Últimas actualizaciones de dividendos

Recent updates

AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 5.4 million.

AnteoTech Limited has filed a Follow-on Equity Offering in the amount of AUD 2.5 million.

We're Keeping An Eye On AnteoTech's (ASX:ADO) Cash Burn Rate

AnteoTech Limited to Report First Half, 2024 Results on Feb 28, 2024

AnteoTech Limited, Annual General Meeting, Nov 14, 2023

AnteoTech Limited, Annual General Meeting, Nov 14, 2023

Full year 2023 earnings released: AU$0.006 loss per share (vs AU$0.005 loss in FY 2022)

New minor risk - Financial data availability

Anteotech Limited Announces Appointment of Mr. Andrew Cook as Chief Financial Officer

AnteoTech Limited to Report Fiscal Year 2023 Results on Aug 30, 2023

New major risk - Share price stability

AnteoTech Limited Announces Retirement of Christopher Parker from the Board of Directors

Will AnteoTech (ASX:ADO) Spend Its Cash Wisely?

Board Member exercised options to buy AU$70k worth of stock.

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)

AnteoTech Limited Appoints Tsui Min Lian as Chief Marketing Officer, Effective 15 March 2023

Non-Executive Director recently sold AU$61k worth of stock

Is AnteoTech (ASX:ADO) In A Good Position To Invest In Growth?

High number of new and inexperienced directors

AnteoTech Ltd Announces Halt of European Rat Clinical Trial to Refocus Initiatives

AnteoTech Limited Appoint Executives

Full year 2022 earnings released: AU$0.005 loss per share (vs AU$0.003 loss in FY 2021)

AnteoTech Limited, Annual General Meeting, Nov 17, 2022

Companies Like AnteoTech (ASX:ADO) Are In A Position To Invest In Growth

AnteoTech Limited Appoints David Radford as Managing Director, Effective from 4 October 2022

AnteoTech Limited SHS to Be Deleted from OTC Equity

Non-Executive Director recently sold AU$106k worth of stock

AnteoTech Ltd Announces Updated COVID-19 RAT Receives Regulatory Approval in Europe

Non-Executive Director recently sold AU$220k worth of stock

High number of new and inexperienced directors

AnteoTech Limited Announces Executive Changes

Companies Like AnteoTech (ASX:ADO) Are In A Position To Invest In Growth

First half 2022 earnings: EPS in line with analyst expectations despite revenue beat

AnteoTech Limited Provides Update on Its Therapeutic Goods Administration Submission

AnteoTech Limited Provides Update on Its Therapeutic Goods Administration Submission

Non-Executive Director recently sold AU$108k worth of stock

Company Secretary Duncan Cornish has left the company

High number of new and inexperienced directors

We Think AnteoTech (ASX:ADO) Can Easily Afford To Drive Business Growth

High number of new and inexperienced directors

Independent Non-Executive Director recently bought AU$59k worth of stock

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Full year 2021 earnings released: AU$0.003 loss per share (vs AU$0.002 loss in FY 2020)

Chief Financial Officer Gail Jukes has left the company

Non-Executive Director recently sold AU$112k worth of stock

AnteoTech Limited has completed a Follow-on Equity Offering in the amount of AUD 12.000001 million.

AnteoTech Limited announced that it expects to receive AUD 12.000001 million in funding

We Think AnteoTech (ASX:ADO) Can Easily Afford To Drive Business Growth

Independent Non-Executive Director has left the company

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.001 loss in 1H 2020)

New 90-day high: AU$0.21

AnteoTech Customer Ellume Secures Us Contract

We're Not Very Worried About AnteoTech's (ASX:ADO) Cash Burn Rate

AnteoTech Progresses COVID-19 Test Toward Market Launch

AnteoTech Ltd Freeze Design of COVID-19 Antigen Rapid Test After Showing Saliva Proxy Sample Use Case Effectiveness

Independent Non-Executive Director exercised options to buy AU$208k worth of stock.

Full year earnings released - AU$0.002 loss per share

Estabilidad y crecimiento de los pagos

Rentabilidad por dividendo vs. Mercado

Pago de beneficios a los accionistas

Pago en efectivo a los accionistas

Discover strong dividend paying companies